We identified 53 epigenetic regulators that control NB growth and/or differentiation SETD8 inhibition activates the p53 pathway by decreasing p53K382me1 levels UNC0379 is a small-molecule inhibitor of SETD8 that activates the p53 pathway SETD8 is validated as a druggable therapeutic target in NB